跳至主要内容
临床试验/ACTRN12620001362987
ACTRN12620001362987已完成未知

Reducing symptom burden in individuals with irritable bowel syndrome (IBS) and comorbid anxiety or depression: Is a Mediterranean diet intervention feasible?

Deakin University0 个研究点目标入组 59 人开始时间: 2020年12月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
59

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Inclusion criteria
  • Aged 18-65 years
  • IBS diagnosis (Rome IV criteria) of any IBS subtype (diarrhea-predominant, constipation-predominant, mixed, un-subtyped)
  • Hospital anxiety and depression score (HADS) subscale score of 8-14, indicating mild or moderately severe anxiety or depressive symptoms
  • Access to computer and internet access

排除标准

  • Known or suspected major medical conditions
  • Females who report to be pregnant or lactating
  • Unable to follow Mediterranean diet study recommendations (e.g. veganism, lacto-ovo vegetarians, inability to follow for sociocultural or religious reasons)
  • Co-existing eating disorder or highly disordered eating
  • Underweight (BMI <18.5 kg/m2) or obesity (>40 kg/m2)
  • Change in IBS or anxiety/depression medication or exposure to pre- or probiotic supplements in the last month or antibiotics or bowel preparation for investigative procedures within the past three months

研究者

相似试验

TANDIM: Treating Anxiety and Depression in Irritable... | 临床试验